Diabetes decisions — 2024

The Board has granted a TDIU effective February 10, 2021, based on the Veteran's service-connected diabetic peripheral neuropathy of the right and left feet.

The Veteran's diabetes mellitus, type II, is currently rated at 20 percent and the Appellant asserts it should be evaluated as 40 percent disabling due to his need to regulate activities.

The Board has granted service connection for diabetes mellitus, type II and gastroesophageal reflux disease (GERD) as secondary to the Veteran's service-connected obstructive sleep apnea.

The Veteran withdrew his appeal for the claims of service connection for erectile dysfunction, diabetes, hypertension, and coronary artery disease.

The Board denied service connection for type II diabetes mellitus, LLE radiculopathy, RLE radiculopathy, cervical spine arthritis, and right hip arthritis. The Veteran's claims were based on his assertions of exposure to herbicides in Korea and equipment handling in Vietnam, but the evidence did not support these claims.

The Board has remanded the Veteran's claims for service connection due to insufficient medical opinions and potential toxic exposure. The claims will be reviewed with consideration of any TERA at Fort McClellan.

The appeals for service connection and ratings related to various conditions have been dismissed due to the Veteran's death.

The Veteran's claims for service connection for diabetes mellitus, type II; peripheral neuropathy of the bilateral upper and lower extremities; vision disability (diabetic retinopathy); Parkinson's disease; and hypothyroidism have been granted due to presumed exposure to herbicide agents during his service in Vietnam.

An earlier effective date of August 31, 2018 for a 20 percent disability rating for diabetes mellitus type II is granted.,An earlier effective date of November 1, 2021 for a 30 percent disability rating for atrial fibrillation is denied. The criteria were not met prior to this date.

The Veteran's service-connected diabetes mellitus and left below-the-knee amputation rendered him in need of regular aid and attendance, which is the basis for SMC. The Board granted this benefit.

The Veteran's PTSD and diabetes mellitus have been granted initial disability ratings of 100% and 40%, respectively, effective as of the date of this decision.

Your service connection for diabetes mellitus, type II has been granted and you are currently receiving a 20% rating. This appeal is dismissed as the issue of service connection for this condition is no longer before the Board.

The Veteran's right and left radial nerve diabetic peripheral neuropathy have been granted service connection as secondary to his service-connected type II diabetes mellitus.,Higher ratings for the Veteran's right and left radial nerve diabetic peripheral neuropathy are denied.

The Board has granted service connection for left hip disability, hypertension, diabetes mellitus type II, steatohepatitis (fatty liver), testicular cancer, and prostatitis. The decision is based on the Veteran's credible reports of symptoms during active duty service and VA medical opinions supporting a finding that these conditions are related to his military service.

The Veteran's claim for an initial compensable rating for diabetic retinopathy was denied as there were no incapacitating episodes and the visual acuity did not meet the criteria for a higher rating.

The Veteran's claims for service connection for heart disability, diabetes mellitus (type II), lower extremity peripheral neuropathy, and erectile dysfunction are being remanded due to the need to address other toxic exposure theories not previously considered.

The Board denied the Veteran's requests for earlier effective dates for service connection awards of diabetes mellitus type II, right lower extremity neuropathy, and left lower extremity neuropathy. The claims were based on presumptive exposure to herbicide agents during service in Thailand, but no such exposure was conceded.

The Board granted service connection for arterioslerotic heart diseases, diabetes melitis type II, hypertension, and erectile dysfunction with specific evaluations. The effective date is August 10, 2022.

Your claim for service connection for diabetes mellitus type II has been fully granted, and the issue is now moot.

The Veteran's depressive disorder due to chronic pain syndrome with depressive features and generalized anxiety disorder are granted as secondary to service-connected conditions. The claim for diabetes mellitus type II, secondary to asthma with pulmonary sarcoidosis, is remanded.